My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Articles published by Celerion

Celerion Welcomes Dr. Steven Evans as Senior Cardiologist to Enhance Cardiovascular Safety in Clinical Trials

November 20, 2025

From Celerion

Via Business Wire

Celerion Earns AAHRPP Full Reaccreditation for Five Years, Strengthening Commitment to Ethical Research Practices

October 09, 2025

From Celerion

Via Business Wire

Celerion Launches Enhanced Version of Labnotes Bioanalytical Data Management Software

May 06, 2025

From Celerion

Via Business Wire

Celerion Expands UK Phase 1 Clinical Research Operations With New Agreement to Relocate to Queen’s University Belfast’s iREACH Health – Clinical Research Innovation Center

February 19, 2025

From Celerion

Via Business Wire

Celerion Pledges Commitment to the Science Based Targets Initiative (SBTi) Net-Zero Standard

December 04, 2024

From Celerion

Via Business Wire

Celerion’s US Pharmacies Expand On-Site Services, Ensure cGMP FDA Compliance for Phase 1 Investigational Drugs

July 17, 2024

From Celerion

Via Business Wire

Celerion Honored With Prestigious CRO Leadership Award for Ninth Consecutive Year

June 05, 2024

From Celerion

Via Business Wire

Jo Goodman Joins Celerion as Vice President of Bioanalytical Services

May 07, 2024

From Celerion

Via Business Wire

Celerion Achieves Milestone With CLIA Certification for Its Bioanalytical Laboratory, Expanding Capabilities in Clinical Trials and Diagnostic Testing

February 06, 2024

From Celerion

Via Business Wire

Celerion Receives a 2023 CRO Leadership Award in All Categories for the Eighth Year Running

May 10, 2023

From Celerion

Via Business Wire

Celerion Expands Its Service Offering to Include GLP/GCP Compliant Molecular and Cell Biology Testing

November 10, 2022

From Celerion

Via Business Wire

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.